JPRN-UMIN000038721
Completed
未知
A study (study No. 2) for evaluating the effects of intake of food containing lactic acid bacteria and oligosaccharide on intestinal environment. A placebo-controlled, randomized, double-blind, cross-over trial. - A study (study No. 2) for evaluating the effects of intake of food containing lactic acid bacteria and oligosaccharide on intestinal environment.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Subjects with a tendency for constipation
- Sponsor
- KSO Corporation
- Enrollment
- 22
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Individuals taking antiflatulents and/or laxatives (including purgative drug) in common use (2\) Individuals taking health foods in common use, which influence intestinal regulation at the point of screening examination (3\) Individuals taking antibiotics and/or drugs which influence laxatives(including purgative drugs) in common use at the point of screening examination (4\) Individuals who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use and food with function claim, which influence intestinal regulation during the study period (5\) Individuals presenting known food allergy (6\) Individuals taking large amounts of alcohol on a daily basis (7\) Individuals who are suffered from a disease which needs treatment urgently or individuals with severe complications (8\) Individuals with a digestive organ disease or surgical history who has an influence on digestive absorption and defecation (9\) Individuals who are judged to be unsuitable as a subject from an answer of a subjective background questionnaire (10\) Individuals who are pregnant or breast\-feeding, or have the will of pregnancy during the study period (11\) Individuals who are under treatment or have a history of drug/alcohol dependence (12\) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (13\) Individuals who are judged as unsuitable for the study by the investigator for the other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
An exploratory phase 2 study to asses the effect of Dapagliflozin on Glomerular Filtration Rate (GFR) in subjects with type 2 Diabetes who have inadequate glycemic and blood pressure (BP) control.Diabetes Mellitus Type 210018424NL-OMON33243Bristol-Myers Squibb15
Recruiting
Phase 2
Phase IIa Study to Characterize the Effects of the Spiegelmer® NOX H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or LymphomaAnemia of Chronic DiseaseD63.0Anaemia in neoplastic diseaseDRKS00004366OXXON Pharma AG48
Not yet recruiting
Not Applicable
The study for evaluating the additional effect of tadalafil in patients with the residual lower urinary tract storage symptoms even after treatment with alpha-1-adrenoreceptor antagonistsBenign prostatic hyperplasia (BPH)JPRN-UMIN000017896Toranomon Hospital100
Not yet recruiting
Not Applicable
Effect of Apatarpankar Hetus on Krusha Pramehi (low BMI Diabetic patients) and their Blood Sugar LevelCTRI/2018/11/016321PDEAs College of Ayurved and Research Center
Not yet recruiting
Not Applicable
Effects of commonly used anti-anxiety drugs on patientsCTRI/2023/01/048752Dr Dnyaneshwar Kurle